APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncology Injection Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oncology Injection Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchOncology Injection Drug Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology Injection Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Oncology Injection Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology Injection Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology Injection Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Oncology Injection Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oncology Injection Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oncology Injection Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oncology Injection Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oncology Injection Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oncology Injection Drug include AdvaCare, Allos Therapeutics, Alza, Celgene, CordenPharma, Debiopharm, Ferring Pharmaceuticals, Genzyme and Merrimack, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oncology Injection Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oncology Injection Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oncology Injection Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oncology Injection Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Oncology Injection Drug Segment by Company

AdvaCare

Allos Therapeutics

Alza

Celgene

CordenPharma

Debiopharm

Ferring Pharmaceuticals

Genzyme

Merrimack

Millennium Pharmaceuticals

Pharmascience

Praecis Pharmaceuticals

S.G. Biopharm

Taj Oncology

Eli Lilly

Oncology Injection Drug Segment by Type

Central Nervous System

Circulatory/Musculoskeletal System

Organs

Other

Oncology Injection Drug Segment by Application

Myeloma

Lymphoma

Prostate Cancer

Other

Oncology Injection Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Injection Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology Injection Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Injection Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oncology Injection Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncology Injection Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oncology Injection Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oncology Injection Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oncology Injection Drug Industry Trends Table 2. Oncology Injection Drug Industry Drivers Table 3. Oncology Injection Drug Industry Opportunities and Challenges Table 4. Oncology Injection Drug Industry Restraints Table 5. Global Oncology Injection Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oncology Injection Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oncology Injection Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Oncology Injection Drug Sales Market Share by Manufacturers Table 9. Global Oncology Injection Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Oncology Injection Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oncology Injection Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oncology Injection Drug Manufacturers, Product Type & Application Table 13. Global Oncology Injection Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oncology Injection Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Central Nervous System Table 17. Major Manufacturers of Circulatory/Musculoskeletal System Table 18. Major Manufacturers of Organs Table 19. Major Manufacturers of Other Table 20. Global Oncology Injection Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 22. Global Oncology Injection Drug Sales by Type (2027-2032) & (K Units) Table 23. Global Oncology Injection Drug Sales Market Share by Type (2021-2026) Table 24. Global Oncology Injection Drug Sales Market Share by Type (2027-2032) Table 25. Global Oncology Injection Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Oncology Injection Drug Revenue by Type (2021-2026) & (K Units) Table 27. Global Oncology Injection Drug Revenue by Type (2027-2032) & (K Units) Table 28. Global Oncology Injection Drug Revenue Market Share by Type (2021-2026) Table 29. Global Oncology Injection Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Myeloma Table 31. Major Manufacturers of Lymphoma Table 32. Major Manufacturers of Prostate Cancer Table 33. Major Manufacturers of Other Table 34. Global Oncology Injection Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 36. Global Oncology Injection Drug Sales by Application (2027-2032) & (K Units) Table 37. Global Oncology Injection Drug Sales Market Share by Application (2021-2026) Table 38. Global Oncology Injection Drug Sales Market Share by Application (2027-2032) Table 39. Global Oncology Injection Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Oncology Injection Drug Revenue by Application (2021-2026) & (K Units) Table 41. Global Oncology Injection Drug Revenue by Application (2027-2032) & (K Units) Table 42. Global Oncology Injection Drug Revenue Market Share by Application (2021-2026) Table 43. Global Oncology Injection Drug Revenue Market Share by Application (2027-2032) Table 44. Global Oncology Injection Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Oncology Injection Drug Sales by Region (2021-2026) & (K Units) Table 46. Global Oncology Injection Drug Sales Market Share by Region (2021-2026) Table 47. Global Oncology Injection Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Oncology Injection Drug Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Oncology Injection Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 51. North America Oncology Injection Drug Sales by Country (2027-2032) & (K Units) Table 52. Europe Oncology Injection Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 54. Europe Oncology Injection Drug Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Oncology Injection Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Oncology Injection Drug Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Oncology Injection Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Oncology Injection Drug Sales by Country (2027-2032) & (K Units) Table 61. Global Oncology Injection Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Oncology Injection Drug Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Oncology Injection Drug Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Oncology Injection Drug Revenue Market Share by Region (2021-2026) Table 65. Global Oncology Injection Drug Revenue Market Share by Region (2027-2032) Table 66. AdvaCare Company Information Table 67. AdvaCare Business Overview Table 68. AdvaCare Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. AdvaCare Oncology Injection Drug Product Portfolio Table 70. AdvaCare Recent Development Table 71. Allos Therapeutics Company Information Table 72. Allos Therapeutics Business Overview Table 73. Allos Therapeutics Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Allos Therapeutics Oncology Injection Drug Product Portfolio Table 75. Allos Therapeutics Recent Development Table 76. Alza Company Information Table 77. Alza Business Overview Table 78. Alza Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Alza Oncology Injection Drug Product Portfolio Table 80. Alza Recent Development Table 81. Celgene Company Information Table 82. Celgene Business Overview Table 83. Celgene Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Celgene Oncology Injection Drug Product Portfolio Table 85. Celgene Recent Development Table 86. CordenPharma Company Information Table 87. CordenPharma Business Overview Table 88. CordenPharma Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. CordenPharma Oncology Injection Drug Product Portfolio Table 90. CordenPharma Recent Development Table 91. Debiopharm Company Information Table 92. Debiopharm Business Overview Table 93. Debiopharm Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Debiopharm Oncology Injection Drug Product Portfolio Table 95. Debiopharm Recent Development Table 96. Ferring Pharmaceuticals Company Information Table 97. Ferring Pharmaceuticals Business Overview Table 98. Ferring Pharmaceuticals Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Ferring Pharmaceuticals Oncology Injection Drug Product Portfolio Table 100. Ferring Pharmaceuticals Recent Development Table 101. Genzyme Company Information Table 102. Genzyme Business Overview Table 103. Genzyme Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Genzyme Oncology Injection Drug Product Portfolio Table 105. Genzyme Recent Development Table 106. Merrimack Company Information Table 107. Merrimack Business Overview Table 108. Merrimack Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Merrimack Oncology Injection Drug Product Portfolio Table 110. Merrimack Recent Development Table 111. Millennium Pharmaceuticals Company Information Table 112. Millennium Pharmaceuticals Business Overview Table 113. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Millennium Pharmaceuticals Oncology Injection Drug Product Portfolio Table 115. Millennium Pharmaceuticals Recent Development Table 116. Pharmascience Company Information Table 117. Pharmascience Business Overview Table 118. Pharmascience Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Pharmascience Oncology Injection Drug Product Portfolio Table 120. Pharmascience Recent Development Table 121. Praecis Pharmaceuticals Company Information Table 122. Praecis Pharmaceuticals Business Overview Table 123. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Praecis Pharmaceuticals Oncology Injection Drug Product Portfolio Table 125. Praecis Pharmaceuticals Recent Development Table 126. S.G. Biopharm Company Information Table 127. S.G. Biopharm Business Overview Table 128. S.G. Biopharm Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. S.G. Biopharm Oncology Injection Drug Product Portfolio Table 130. S.G. Biopharm Recent Development Table 131. Taj Oncology Company Information Table 132. Taj Oncology Business Overview Table 133. Taj Oncology Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Taj Oncology Oncology Injection Drug Product Portfolio Table 135. Taj Oncology Recent Development Table 136. Eli Lilly Company Information Table 137. Eli Lilly Business Overview Table 138. Eli Lilly Oncology Injection Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Eli Lilly Oncology Injection Drug Product Portfolio Table 140. Eli Lilly Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Oncology Injection Drug Distributors List Table 144. Oncology Injection Drug Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Oncology Injection Drug Product Image Figure 2. Global Oncology Injection Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncology Injection Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Oncology Injection Drug Sales (2021-2032) & (K Units) Figure 5. Global Oncology Injection Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oncology Injection Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Central Nervous System Image Figure 9. Circulatory/Musculoskeletal System Image Figure 10. Organs Image Figure 11. Other Image Figure 12. Global Oncology Injection Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Oncology Injection Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Oncology Injection Drug Sales Market Share by Type (2021-2032) Figure 15. Global Oncology Injection Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Oncology Injection Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Oncology Injection Drug Revenue Market Share by Type (2021-2032) Figure 18. Myeloma Image Figure 19. Lymphoma Image Figure 20. Prostate Cancer Image Figure 21. Other Image Figure 22. Global Oncology Injection Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Oncology Injection Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Oncology Injection Drug Sales Market Share by Application (2021-2032) Figure 25. Global Oncology Injection Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Oncology Injection Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Oncology Injection Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Oncology Injection Drug Sales Market Share by Country (2021-2032) Figure 30. U.S. Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Oncology Injection Drug Sales Market Share by Country (2021-2032) Figure 35. Germany Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Oncology Injection Drug Sales Market Share by Country (2021-2032) Figure 42. China Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Oncology Injection Drug Sales Market Share by Country (2021-2032) Figure 50. Brazil Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Oncology Injection Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Oncology Injection Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Oncology Injection Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Figure 61. North America Oncology Injection Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Figure 63. Europe Oncology Injection Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Oncology Injection Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Oncology Injection Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Oncology Injection Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Oncology Injection Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Central Nervous System
  • Circulatory/Musculoskeletal System
  • Organs
  • Other
Applications
  • Myeloma
  • Lymphoma
  • Prostate Cancer
  • Other
Companies covered
  • AdvaCare
  • Allos Therapeutics
  • Alza
  • Celgene
  • CordenPharma
  • Debiopharm
  • Ferring Pharmaceuticals
  • Genzyme
  • Merrimack
  • Millennium Pharmaceuticals
  • Pharmascience
  • Praecis Pharmaceuticals
  • S.G. Biopharm
  • Taj Oncology
  • Eli Lilly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oncology Injection Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oncology Injection Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oncology Injection Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oncology Injection Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oncology Injection Drug Market Dynamics
  1. 2.1 Oncology Injection Drug Industry Trends
  2. 2.2 Oncology Injection Drug Industry Drivers
  3. 2.3 Oncology Injection Drug Industry Opportunities and Challenges
  4. 2.4 Oncology Injection Drug Industry Restraints
3 Oncology Injection Drug Market by Manufacturers
  1. 3.1 Global Oncology Injection Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oncology Injection Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oncology Injection Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oncology Injection Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oncology Injection Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oncology Injection Drug Manufacturers, Product Type & Application
  7. 3.7 Global Oncology Injection Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oncology Injection Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oncology Injection Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oncology Injection Drug Tier 1, Tier 2, and Tier 3
4 Oncology Injection Drug Market by Type
  1. 4.1 Oncology Injection Drug Type Introduction
  2. 4.1.1 Central Nervous System
  3. 4.1.2 Circulatory/Musculoskeletal System
  4. 4.1.3 Organs
  5. 4.1.4 Other
  6. 4.2 Global Oncology Injection Drug Sales by Type
  7. 4.2.1 Global Oncology Injection Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Oncology Injection Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Oncology Injection Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Oncology Injection Drug Revenue by Type
  11. 4.3.1 Global Oncology Injection Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Oncology Injection Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Oncology Injection Drug Revenue Market Share by Type (2021-2032)
5 Oncology Injection Drug Market by Application
  1. 5.1 Oncology Injection Drug Application Introduction
  2. 5.1.1 Myeloma
  3. 5.1.2 Lymphoma
  4. 5.1.3 Prostate Cancer
  5. 5.1.4 Other
  6. 5.2 Global Oncology Injection Drug Sales by Application
  7. 5.2.1 Global Oncology Injection Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Oncology Injection Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Oncology Injection Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Oncology Injection Drug Revenue by Application
  11. 5.3.1 Global Oncology Injection Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Oncology Injection Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Oncology Injection Drug Revenue Market Share by Application (2021-2032)
6 Global Oncology Injection Drug Sales by Region
  1. 6.1 Global Oncology Injection Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oncology Injection Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Oncology Injection Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Oncology Injection Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oncology Injection Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oncology Injection Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oncology Injection Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oncology Injection Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oncology Injection Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oncology Injection Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oncology Injection Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oncology Injection Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oncology Injection Drug Revenue by Region
  1. 7.1 Global Oncology Injection Drug Revenue by Region
  2. 7.1.1 Global Oncology Injection Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oncology Injection Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Oncology Injection Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Oncology Injection Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oncology Injection Drug Revenue (2021-2032)
  8. 7.2.2 North America Oncology Injection Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oncology Injection Drug Revenue (2021-2032)
  11. 7.3.2 Europe Oncology Injection Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oncology Injection Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oncology Injection Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oncology Injection Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oncology Injection Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AdvaCare
  2. 8.1.1 AdvaCare Company Information
  3. 8.1.2 AdvaCare Business Overview
  4. 8.1.3 AdvaCare Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AdvaCare Oncology Injection Drug Product Portfolio
  6. 8.1.5 AdvaCare Recent Developments
  7. 8.2 Allos Therapeutics
  8. 8.2.1 Allos Therapeutics Company Information
  9. 8.2.2 Allos Therapeutics Business Overview
  10. 8.2.3 Allos Therapeutics Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Allos Therapeutics Oncology Injection Drug Product Portfolio
  12. 8.2.5 Allos Therapeutics Recent Developments
  13. 8.3 Alza
  14. 8.3.1 Alza Company Information
  15. 8.3.2 Alza Business Overview
  16. 8.3.3 Alza Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Alza Oncology Injection Drug Product Portfolio
  18. 8.3.5 Alza Recent Developments
  19. 8.4 Celgene
  20. 8.4.1 Celgene Company Information
  21. 8.4.2 Celgene Business Overview
  22. 8.4.3 Celgene Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Celgene Oncology Injection Drug Product Portfolio
  24. 8.4.5 Celgene Recent Developments
  25. 8.5 CordenPharma
  26. 8.5.1 CordenPharma Company Information
  27. 8.5.2 CordenPharma Business Overview
  28. 8.5.3 CordenPharma Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CordenPharma Oncology Injection Drug Product Portfolio
  30. 8.5.5 CordenPharma Recent Developments
  31. 8.6 Debiopharm
  32. 8.6.1 Debiopharm Company Information
  33. 8.6.2 Debiopharm Business Overview
  34. 8.6.3 Debiopharm Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Debiopharm Oncology Injection Drug Product Portfolio
  36. 8.6.5 Debiopharm Recent Developments
  37. 8.7 Ferring Pharmaceuticals
  38. 8.7.1 Ferring Pharmaceuticals Company Information
  39. 8.7.2 Ferring Pharmaceuticals Business Overview
  40. 8.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ferring Pharmaceuticals Oncology Injection Drug Product Portfolio
  42. 8.7.5 Ferring Pharmaceuticals Recent Developments
  43. 8.8 Genzyme
  44. 8.8.1 Genzyme Company Information
  45. 8.8.2 Genzyme Business Overview
  46. 8.8.3 Genzyme Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genzyme Oncology Injection Drug Product Portfolio
  48. 8.8.5 Genzyme Recent Developments
  49. 8.9 Merrimack
  50. 8.9.1 Merrimack Company Information
  51. 8.9.2 Merrimack Business Overview
  52. 8.9.3 Merrimack Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merrimack Oncology Injection Drug Product Portfolio
  54. 8.9.5 Merrimack Recent Developments
  55. 8.10 Millennium Pharmaceuticals
  56. 8.10.1 Millennium Pharmaceuticals Company Information
  57. 8.10.2 Millennium Pharmaceuticals Business Overview
  58. 8.10.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Millennium Pharmaceuticals Oncology Injection Drug Product Portfolio
  60. 8.10.5 Millennium Pharmaceuticals Recent Developments
  61. 8.11 Pharmascience
  62. 8.11.1 Pharmascience Company Information
  63. 8.11.2 Pharmascience Business Overview
  64. 8.11.3 Pharmascience Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pharmascience Oncology Injection Drug Product Portfolio
  66. 8.11.5 Pharmascience Recent Developments
  67. 8.12 Praecis Pharmaceuticals
  68. 8.12.1 Praecis Pharmaceuticals Company Information
  69. 8.12.2 Praecis Pharmaceuticals Business Overview
  70. 8.12.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Praecis Pharmaceuticals Oncology Injection Drug Product Portfolio
  72. 8.12.5 Praecis Pharmaceuticals Recent Developments
  73. 8.13 S.G. Biopharm
  74. 8.13.1 S.G. Biopharm Company Information
  75. 8.13.2 S.G. Biopharm Business Overview
  76. 8.13.3 S.G. Biopharm Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 S.G. Biopharm Oncology Injection Drug Product Portfolio
  78. 8.13.5 S.G. Biopharm Recent Developments
  79. 8.14 Taj Oncology
  80. 8.14.1 Taj Oncology Company Information
  81. 8.14.2 Taj Oncology Business Overview
  82. 8.14.3 Taj Oncology Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Taj Oncology Oncology Injection Drug Product Portfolio
  84. 8.14.5 Taj Oncology Recent Developments
  85. 8.15 Eli Lilly
  86. 8.15.1 Eli Lilly Company Information
  87. 8.15.2 Eli Lilly Business Overview
  88. 8.15.3 Eli Lilly Oncology Injection Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Eli Lilly Oncology Injection Drug Product Portfolio
  90. 8.15.5 Eli Lilly Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oncology Injection Drug Value Chain Analysis
  2. 9.1.1 Oncology Injection Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oncology Injection Drug Production Mode & Process
  6. 9.2 Oncology Injection Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oncology Injection Drug Distributors
  9. 9.2.3 Oncology Injection Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst